The aims of the session are to identify prognostic markers in order to predict disease clinical course and guide treatment of connective tissue disease-associated interstitial lung diseases (CTD-ILD).   The audience will gain knowledge on the diagnostic/prognostic challenges and novel therapeutic advances in CTD-ILD.